Trials / Completed
CompletedNCT06064838
Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC)
Effects of Cacao Flavonoids in Long COVID-19 Patients with Chronic Fatigue (FLALOC)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Guillermo Ceballos Reyes · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study use a triple blind, placebo-controlled design enrolling male and female subjects between 30-70 yo to evaluate the effect of daily consumption of a cacao supplement on inflammation, endothelial damage, handgrip strength, fatigue scale and quality of life.
Detailed description
The study use a triple blind, placebo-controlled design enrolling male and female subjects between 30-70 yo distributed homogeneously at random in two groups: the control group (Placebo) and the intervention group (Cacao Flavonoids) both groups affected for 90 days. The variables to consider will be: Interleukins (IL-1b, IL-6), Tumoral Necrosis Factor alpha (TNF-α) and syndecan-1. For physical performance is evaluated the handgrip strength. The investigators also assessed quality of life using the Health Related QoL (EQ-5D) questionnaire, and the numerical fatigue rating scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Flavonoids | 1 capsule every 12h for 90 days |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-08-01
- Completion
- 2024-09-30
- First posted
- 2023-10-03
- Last updated
- 2024-10-01
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT06064838. Inclusion in this directory is not an endorsement.